• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞减少儿童中黏液性口腔球菌所致菌血症的并发症

Complications of bacteremia due to Stomatococcus mucilaginosus in neutropenic children.

作者信息

Henwick S, Koehler M, Patrick C C

机构信息

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee 38101-0318.

出版信息

Clin Infect Dis. 1993 Oct;17(4):667-71. doi: 10.1093/clinids/17.4.667.

DOI:10.1093/clinids/17.4.667
PMID:8268348
Abstract

Stomatococcus mucilaginosus, a normal inhabitant of the human oral cavity and upper respiratory tract, can cause fatal sepsis and meningitis in neutropenic patients. We identified eight cases of bacteremia due to S. mucilaginosus in children with cancer, of whom five developed complications despite receiving appropriate antibiotics. At the time cultures were positive, seven patients had profound neutropenia (< 100 neutrophils and band forms/mm3) and four had mucositis; five had central venous catheters. In two cases, there was unequivocal evidence of catheter-related sepsis. Bacteremia was eradicated in all patients within 48 hours after initiation of antibiotics. Despite prompt instigation of effective antibiotic therapy, the complication rates in this series were high: septic shock (50%), pneumonia (50%), dermatologic manifestations (38%), altered neurological status (25%), meningitis (13%), and adult respiratory distress syndrome (13%). No fatalities were attributable to S. mucilaginosus infection. These cases illustrate the virulence of S. mucilaginosus organisms in neutropenic children and suggest a substantial risk of sequelae even when adequate antibiotic therapy is given.

摘要

黏性口腔球菌是人类口腔和上呼吸道的正常寄居菌,可在中性粒细胞减少的患者中引起致命的败血症和脑膜炎。我们鉴定出8例癌症患儿发生了由黏性口腔球菌引起的菌血症,其中5例尽管接受了适当的抗生素治疗仍出现了并发症。在培养结果呈阳性时,7例患者有严重的中性粒细胞减少(<100个中性粒细胞和杆状核细胞/mm³),4例有黏膜炎;5例有中心静脉导管。在2例中,有明确的导管相关败血症证据。所有患者在开始使用抗生素后48小时内菌血症均被根除。尽管迅速启动了有效的抗生素治疗,但该系列中的并发症发生率仍很高:感染性休克(50%)、肺炎(50%)、皮肤表现(38%)、神经状态改变(25%)、脑膜炎(13%)和成人呼吸窘迫综合征(13%)。没有死亡病例归因于黏性口腔球菌感染。这些病例说明了黏性口腔球菌在中性粒细胞减少儿童中的毒力,并表明即使给予了充分的抗生素治疗,仍有很大的后遗症风险。

相似文献

1
Complications of bacteremia due to Stomatococcus mucilaginosus in neutropenic children.中性粒细胞减少儿童中黏液性口腔球菌所致菌血症的并发症
Clin Infect Dis. 1993 Oct;17(4):667-71. doi: 10.1093/clinids/17.4.667.
2
Severe infection caused by Stomatococcus mucilaginosus in a neutropenic patient: case report and review of the literature.1例中性粒细胞减少患者发生粘质口腔球菌严重感染:病例报告及文献复习
Hematol Cell Ther. 1998 Aug;40(4):167-9.
3
Bacteremia due to Stomatococcus mucilaginosus in neutropenic patients in the setting of a cancer institute.在一家癌症研究所的背景下,中性粒细胞减少患者中由黏性口腔球菌引起的菌血症。
Clin Microbiol Infect. 2003 Oct;9(10):1068-72. doi: 10.1046/j.1469-0691.2003.00772.x.
4
Bactericidal activity in cerebrospinal fluid by treating meningitis caused by Stomatococcus mucilaginosus with rifampicin, cefotaxime and vancomycin in a neutropenic child.利福平、头孢噻肟和万古霉素治疗中性粒细胞减少儿童黏液性口腔球菌性脑膜炎时脑脊液中的杀菌活性
Clin Microbiol Infect. 2001 Jan;7(1):39-42.
5
[Stomatococcus mucilaginosus meningitis in immunocompromised child].免疫功能低下儿童的黏性口腔球菌性脑膜炎
Arch Pediatr. 1994 Sep;1(9):813-5.
6
Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients.黏性口腔球菌:中性粒细胞减少患者中的一种新兴病原体。
Clin Infect Dis. 1992 Mar;14(3):641-6. doi: 10.1093/clinids/14.3.641.
7
[Bacteremia caused by Stomatococcus mucilaginosus in a neutropenic patient].
Enferm Infecc Microbiol Clin. 1999 Jan;17(1):42-3.
8
Infections due to Stomatococcus mucilaginosus: 10 cases and review.粘质口腔球菌感染:10例报告并文献复习
Rev Infect Dis. 1991 Nov-Dec;13(6):1048-52. doi: 10.1093/clinids/13.6.1048.
9
Stomatococcus mucilaginosus meningitis in a healthy 2-month-old child.一名健康2个月大婴儿患黏性口腔球菌性脑膜炎。
J Med Microbiol. 2008 Mar;57(Pt 3):382-383. doi: 10.1099/jmm.0.47512-0.
10
Bacteremia caused by Stomatococcus mucilaginosus: report of seven cases and review of the literature.黏液性口腔球菌引起的菌血症:7例报告及文献复习
Infection. 1992 Jul-Aug;20(4):213-20. doi: 10.1007/BF02033062.

引用本文的文献

1
New Phage-Derived Antibacterial Enzyme PolaR Targeting spp.新型噬菌体衍生抗菌酶 PolaR 靶向 spp.
Cells. 2023 Aug 4;12(15):1997. doi: 10.3390/cells12151997.
2
Rothia mucilaginosa Infections in Pediatric Cancer Patients.黏罗斯菌属感染与儿科癌症患者。
J Pediatric Infect Dis Soc. 2021 Apr 3;10(3):341-344. doi: 10.1093/jpids/piaa047.
3
Rothia bacteremia: a 10-year experience at Mayo Clinic, Rochester, Minnesota.罗思氏菌血症:明尼苏达州罗切斯特市梅奥诊所的10年经验
J Clin Microbiol. 2014 Sep;52(9):3184-9. doi: 10.1128/JCM.01270-14. Epub 2014 Jun 20.
4
Association of Stomatococcus mucilaginosus with cholangitis.
Eur J Clin Microbiol Infect Dis. 1994 Jul;13(7):606-8. doi: 10.1007/BF01971315.
5
Stomatococcus mucilaginosus produces a mannose-containing lipoglycan rather than lipoteichoic acid.粘性口腔球菌产生含甘露糖的脂多糖而不是脂磷壁酸。
Arch Microbiol. 1995 Jan;163(1):70-5. doi: 10.1007/BF00262206.
6
Antimicrobial susceptibilities of Stomatococcus mucilaginosus and of Micrococcus spp.黏性口腔球菌和微球菌属的抗菌药敏性
Antimicrob Agents Chemother. 1995 Jan;39(1):268-70. doi: 10.1128/AAC.39.1.268.